Generix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 4.00 Cr
as on 05-12-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.90 Cr
as on 05-12-2024
- Satisfied Charges ₹ 4.58 Cr
as on 05-12-2024
- Revenue -17.01%
(FY 2023)
- Profit 44.52%
(FY 2023)
- Ebitda 37.23%
(FY 2023)
- Net Worth -36.85%
(FY 2023)
- Total Assets -10.91%
(FY 2023)
About Generix Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹8.90 Cr. The company has closed loans amounting to ₹4.58 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Jha and Rekha Jha serve as directors at the Company.
- CIN/LLPIN
U24110DL2007PTC164689
- Company No.
164689
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Generix Lifesciences Private Limited offer?
Generix Lifesciences Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Health Conditions, Kidney Care.
Who are the key members and board of directors at Generix Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Jha  | Director | 13-Jun-2007 | Current |
| Rekha Jha | Director | 26-Nov-2020 | Current |
Financial Performance of Generix Lifesciences.
Generix Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.01% decrease. The company also saw a substantial improvement in profitability, with a 44.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Generix Lifesciences?
Unlock access to Generix Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Aug 2017 | ₹8.90 Cr | Open |
Others Creation Date: 27 Jun 2016 | ₹1.05 Cr | Satisfied |
Edelweiss Retail Finance Limited Creation Date: 29 Jan 2015 | ₹1.87 Cr | Satisfied |
How Many Employees Work at Generix Lifesciences?
Generix Lifesciences has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Generix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
